The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented ¹⁰B conjugate compound, TX-2100, for boron neutron capture therapy

References

• Barth RF, Coderre JA, Vicente MGH, Blue TE. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 2005; 11: 3987–4002
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res 2002; 43: 11–25
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Yamashita M, Mikamo N, Shimamura M, Oka S, Uto Y, Hori H. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives. Comp Biochem Physiol A Mol Integr Physiol 2002; 132: 33–40
   PubMedGoogle Scholar
• Griffin RJ, Okajima K, Ogawa A, Song CW. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. Int J Radiat Biol 1999; 75: 1299–1306
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y. Modification of tirapazamine-induced cytotoxicity in combination with mild Hyperthermia and/or nicotinamide: Reference to effect on quiescent tumour cells. Int J Hyperthermia 1999; 15: 7–16
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M. Modification of the response of a quiescent cell population with a murine solid tumour to boron neutron capture irradiation: Studies with nicotinamide and hyperthermia. Br J Radiol 1997; 70: 391–398
   PubMedGoogle Scholar
• Masunaga S, Nagasawa H, Gotoh K, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K. Evaluation of hypoxia-specific bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy. Radiat Med 2006; 24: 98–107
   PubMedGoogle Scholar
• Hori H, Jin C-Z, Kiyono M, Shimamura M, Inayama S. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacrtylcarbamoyl-2-nitroimidazoles. Bioorg Med Chem 1997; 5: 591–599
   PubMedGoogle Scholar
• Kobayashi T, Kanda K. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry. Nucl Instrum Meth 1983; 204: 525–531
   Web of Science ®Google Scholar
• Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res 1990; 122: 161–167
   PubMed Web of Science ®Google Scholar
• Caswell RS, Coyne JJ, Randolph ML. Kerma factors for neutron energies below 30 MeV. Radiat Res 1980; 83: 217–254
   Web of Science ®Google Scholar
• Sakurai Y, Kobayashi T. Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instr Meth Phys Res A 2000; 453: 569–596
   Web of Science ®Google Scholar
• Brown JM. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol Med Today 2000; 6: 157–162
   PubMedGoogle Scholar
• Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Suzuki M, Kinashi Y, Akaboshi M. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios. Int J Radiat Oncol Biol Phys 1998; 41: 1163–1170
   PubMedGoogle Scholar
• Masunaga S, Ono K, Akaboshi M, Nishimura Y, Suzuki M, Kinashi Y, Takagaki M, Hiraoka M, Abe M. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: Special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Br J Cancer 1997; 7: 588–593
   Google Scholar
• Song CW, Park HJ, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001; 155: 515–528
   PubMed Web of Science ®Google Scholar
• Song CW, Park HJ, Lee CK, Griffin RJ. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005; 21: 761–767
   PubMed Web of Science ®Google Scholar
• Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Rel 2004; 98: 195–207
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures—reference to the effect on intratumor quiescent cells. Jpn J Cancer Res 2000; 91: 566–572
   PubMedGoogle Scholar
• Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumor cell populations. Int J Hyperthermia 2005; 21: 305–318
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kelleher DK, Hoeckel M. Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001; 28(Suppl 8)29–35
   PubMedGoogle Scholar
• Masunaga S, Ono K, Abe M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumors. Br J Radiol 1993; 66: 918–926
   PubMed Web of Science ®Google Scholar
• Brown JM, Giaccia AJ. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408–1416
   PubMed Web of Science ®Google Scholar